List of Excipients in API phenylephrine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing phenylephrine hydrochloride
Excipients in ANDA-approved (generic) drugs containing phenylephrine hydrochloride
Detailed excipient profiles for phenylephrine hydrochloride
Excipient focus: BENZALKONIUM CHLORIDE
phenylephrine hydrochloride drug variants containing BENZALKONIUM CHLORIDE
phenylephrine hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BORIC ACID
phenylephrine hydrochloride drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-102 |
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-103 |
| Bausch & Lomb Americas Inc | phenylephrine hydrochloride | 82260-102 |
| >Company | >Ingredient | >NDC |
phenylephrine hydrochloride drug variants not containing BORIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
phenylephrine hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
phenylephrine hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: HYDROCHLORIC ACID
phenylephrine hydrochloride drug variants containing HYDROCHLORIC ACID
phenylephrine hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: NITROGEN
phenylephrine hydrochloride drug variants containing NITROGEN
phenylephrine hydrochloride drug variants not containing NITROGEN
Excipient focus: PHOSPHORIC ACID
phenylephrine hydrochloride drug variants containing PHOSPHORIC ACID
phenylephrine hydrochloride drug variants not containing PHOSPHORIC ACID
Excipient focus: SODIUM CHLORIDE
phenylephrine hydrochloride drug variants containing SODIUM CHLORIDE
phenylephrine hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
phenylephrine hydrochloride drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | phenylephrine hydrochloride | 0781-3422 |
| Par Pharmaceutical Inc | phenylephrine hydrochloride | 42023-213 |
| Par Pharmaceutical Inc | phenylephrine hydrochloride | 42023-214 |
| >Company | >Ingredient | >NDC |
phenylephrine hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
phenylephrine hydrochloride drug variants containing SODIUM HYDROXIDE
phenylephrine hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | phenylephrine hydrochloride | 43598-172 |
| Eton Pharmaceuticals Inc | phenylephrine hydrochloride | 71863-202 |
| Eton Pharmaceuticals Inc | phenylephrine hydrochloride | 71863-208 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
phenylephrine hydrochloride drug variants containing SODIUM METABISULFITE
phenylephrine hydrochloride drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
phenylephrine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-102 |
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-103 |
| Bausch & Lomb Americas Inc | phenylephrine hydrochloride | 82260-102 |
| >Company | >Ingredient | >NDC |
phenylephrine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
phenylephrine hydrochloride drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
phenylephrine hydrochloride drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
phenylephrine hydrochloride drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-102 |
| Paragon BioTeck Inc | phenylephrine hydrochloride | 42702-103 |
| Bausch & Lomb Americas Inc | phenylephrine hydrochloride | 82260-102 |
| >Company | >Ingredient | >NDC |
phenylephrine hydrochloride drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
phenylephrine hydrochloride drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
phenylephrine hydrochloride drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Excipient focus: TRISODIUM CITRATE DIHYDRATE
phenylephrine hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
phenylephrine hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
phenylephrine hydrochloride drug variants containing WATER
phenylephrine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
